The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
JYNTThe Joint (JYNT) Zacks Investment Research·2024-03-12 00:11

The Joint Corp. (JYNT) shares have jumped 30% since it reported fourth-quarter 2023 financial results. The strong quarterly results were primarily due to continued organic growth and an increased number of clinics, partially offset by higher expenses. In the quarter under review, it witnessed an adjusted earnings per share of 7 cents, beating the Zacks Consensus Estimate of 3 cents. The bottom line also improved from adjusted earnings of 4 cents per share a year ago. Revenues of The Joint amounted to $30.6 ...